Brighton Jones’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
Brighton Jones's FATE Position: Q3 2026 in Review
Brighton Jones sold out of Fate Therapeutics (FATE) in Q3 2026, closing a stake of 33,271 shares — an estimated $89.8K sold.
Brighton Jones first reported a position in FATE in Q1 2026 and held it in 2 quarters. The position peaked at $89.8K in Q2 2026. 117 funds tracked by Wall St. Rank hold FATE as of Q3 2026.
- Brighton Jones reported no remaining Fate Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 33,271 Fate Therapeutics shares in Q3 2026, an estimated $89.8K.
- Brighton Jones first reported a position in Fate Therapeutics in Q1 2026 and held it in 2 quarters.
- Brighton Jones's Fate Therapeutics position peaked at $89.8K in Q2 2026.
- 117 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.